Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Gw Pharma ADR (GWPH)

Gw Pharma ADR (GWPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Gw Pharma ADR SOVEREIGN HOUSE VISION PARK HISTON CAMBRIDGE X0 CB24 9BZ GBR

P: 44-12-2326-6800

Description:

GW Pharmaceuticals plc is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, Sativex is used for the treatment of MS symptoms, cancer pain, and neuropathic pain. It operates primarily in the United Kingdom, Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc is based in Salisbury, the United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 3,069,230
Shares Outstanding, K 30,890
Annual Sales, $ 12,730 K
Annual Net Income, $ -295,160 K
Last Quarter Sales, $ 90,970 K
Last Quarter Net Income, $ -13,760 K
60-Month Beta 2.28
% of Insider Shareholders 3.60%
% of Institutional Shareholders 83.23%
Float, K 29,778
% Float 96.40%

Growth:

1-Year Return -20.29%
3-Year Return -15.42%
5-Year Return 28.32%
5-Year Revenue Growth 2.66%
5-Year Earnings Growth -1,689.83%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.04 on 11/05/19
Next Earnings Date N/A
Earnings Per Share ttm -5.29
EPS Growth vs. Prev Qtr 38.46%
EPS Growth vs. Prev Year 82.61%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

GWPH Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -23.63
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -23.04
Return-on-Assets (Before Tax) -19.72
Profit Margin % -2,318.62
Net Margin % N/A
Debt/Equity 0.03
Price/Sales 240.61
Price/Cash Flow N/A
Price/Book 4.45
Book Value/Share 23.30
Interest Coverage -233.98
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar